Post by
Trogarzon on Dec 02, 2024 8:39am
Dept restructuring
Can't find anything wrong with it.... seems non dilutive... more flexibility... freeing up 20M....nothing on covennants but might remove this sword above their head and ours.
Comment by
muslix1 on Dec 02, 2024 9:15am
I prefer TD lest sshark i think
Comment by
Trogarzon on Dec 02, 2024 10:08am
Ok F8 resubmitted, Marathon is OUT, now pls adress Egrifta supply issue asap, deliver on Th1902 results and partnership and accreditive acquisition front and we're back to 10$. Best wishes....
Comment by
Maxmoe on Dec 02, 2024 10:10am
Finally a catalyst to get this thing rocking
Comment by
PWIB123 on Dec 02, 2024 1:51pm
Thanks for sharing this. Now we just need investors to buy-in (pun intended), TH-1902 to show positive results, a capital partner to come to the table, and a new line of business to generate more revenue and profit to get to a $30 stock, where I will finally breakeven on my most expensive shares. What a disaster! I'll take $3.80 for now as a stepping stone.
Comment by
Maxmoe on Dec 02, 2024 2:03pm
I suggest you remove your rear view mirror. And maybe the vanity mirror. Don't lose the focus out the windshield. Forget the $30 ancient history. Watch the path to $3.80 and watch out for another axle busting pot hole if there is one. Trade around it.
Comment by
Maxmoe on Dec 02, 2024 9:25pm
Well good luck of course. We all win if you do that's for sure. New name for me. I haven't bought a Canadian pharma or biotech name for decades. Biochem Pharma . Forgive me shooter, I didn't realize you were holding $millions. I assumed 20-30-50,000 trading most days in Canada plus 10-20 in USA was enough. Maybe some steady good news will also increase liquidity.
Comment by
Trogarzon on Dec 02, 2024 10:24am
It's a good bank that does'nt pull the rug like other Canadian based banks.